Artificial Pancreas Trondheim: Position 1: Clinical aspects of intraperitoneal glucose measurement
- Prosjektnummer
- 46056927
- Ansvarlig person
- Marte Kierulf Åm
- Institusjon
- NTNU, IKOM
- Prosjektkategori
- Doktorgradsstipend
- Helsekategori
- Metabolic and Endocrine
- Forskningsaktivitet
- 5. Treatment Developement, 7. Disease Management
Why intraperitoneal glucose sensing is sometimes surprisingly rapid and sometimes slow: A hypothesis.
Med Hypotheses 2019 Nov;132():109318. Epub 2019 jul 20
PMID: 31421420 - Inngår i doktorgradsavhandlingen
Intraperitoneal, subcutaneous and intravenous glucagon delivery and subsequent glucose response in rats: a randomized controlled crossover trial.
BMJ Open Diabetes Res Care 2018;6(1):e000560. Epub 2018 nov 9
PMID: 30487972 - Inngår i doktorgradsavhandlingen
Effect of sensor location on continuous intraperitoneal glucose sensing in an animal model.
PLoS One 2018;13(10):e0205447. Epub 2018 okt 9
PMID: 30300416 - Inngår i doktorgradsavhandlingen
Intraperitoneal glucose measuring using amperometric glucose sensors and intraperitoneal fluid samples in an animal model
Advanced Technologies & Treatments for Diabetes (ATTD) 2017
Set-up and procedure for intraperitoneal glucose monitoring in anaesthetised animals
Advanced Technologies & Treatments for Diabetes (ATTD) 2017
Intraperitoneal, subcutaneous and intravenous glucagon delivery in rats: Effect on glucose levels
Advanced Technologies & Treatments for Diabetes (ATTD) 2018
Erratum to" Why intraperitoneal glucose sensing is sometimes surprisingly rapid and sometimes slow: A hypothesis"[Med. Hypotheses 132 (2019) 109318].
Medical hypotheses, 2020
Why intraperitoneal glucose sensing is sometimes suprisingly rapid and sometimes slow: A hypothesis
Advanced Technologies & Treatments for Diabetes (ATTD) 2019
Intraperitoneal and subcutaneous glucagon delivery in pigs: Effects on circulating glucagon and glucose levels
Advanced Technologies & Treatments for Diabetes (ATTD) 2019
Intraperitoneal insulin administration in pigs: Effect on circulating insulin and glucose levels
Advanced Technologies & Treatments for Diabetes (ATTD) 2019
- Anders Lyngvi Fougner Medveileder, biveileder
- Sven Magnus Carlsen Prosjektleder
- Sverre Christian Christiansen Hovedveileder
- Marte Kierulf Åm Doktorgradsstipendiat
eRapport er utarbeidet av Sølvi Lerfald og Reidar Thorstensen, Regionalt kompetansesenter for klinisk forskning, Helse Vest RHF, og videreutvikles av de fire RHF-ene i fellesskap, med støtte fra Helse Vest IKT
Alle henvendelser rettes til Helse Midt-Norge RHF - Samarbeidsorganet og FFU